Suppr超能文献

特发性肺动脉高压患者行肺移植,术中及术后长时间体外膜肺氧合可提供最佳控制的再灌注,获得极佳的预后。

Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome.

机构信息

Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.

Department of Thoracic Surgery, National Institute of Oncology, Semmelweis University, Budapest, Hungary.

出版信息

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):178-185. doi: 10.1093/ejcts/ezx212.

Abstract

OBJECTIVES

Lung transplantation for idiopathic pulmonary arterial hypertension has the highest reported postoperative mortality of all indications. Reasons lie in the complexity of treatment of these patients and the frequent occurrence of postoperative left ventricular failure. Transplantation on intraoperative extracorporeal membrane oxygenation support instead of cardiopulmonary bypass and even more the prolongation of extracorporeal membrane oxygenation into the postoperative period helps to overcome these problems. We reviewed our experience with this concept.

METHODS

All patients undergoing bilateral lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative extracorporeal membrane oxygenation with or without prophylactic extracorporeal membrane oxygenation prolongation into the postoperative period between January 2000 and December 2014 were retrospectively analysed.

RESULTS

Forty-one patients entered the study. Venoarterial extracorporeal membrane oxygenation support was prolonged into the postoperative period for a median of 2.5 days (range 1-40). Ninety-day, 1-, 3- and 5-year survival rates for the patient collective were 92.7%, 90.2%, 87.4% and 87.4%, respectively. When compared with 31 patients with idiopathic pulmonary arterial hypertension transplanted in the same period of time without prolongation of extracorporeal membrane oxygenation into the postoperative period, the results compared favourably (83.9%, 77.4%, 77.4%, and 77.4%; P = 0.189). Furthermore, these results are among the best results ever reported for this particularly difficult patient population.

CONCLUSIONS

Bilateral lung transplantation for idiopathic pulmonary arterial hypertension with intraoperative venoarterial extracorporeal membrane oxygenation support seems to provide superior outcome compared with the results reported about the use of cardiopulmonary bypass. Prophylactic prolongation of venoarterial extracorporeal membrane oxygenation into the early postoperative period provides stable postoperative conditions and seems to further improve the results.

摘要

目的

特发性肺动脉高压患者进行肺移植术后的死亡率在所有适应证中报告最高。原因在于这些患者的治疗复杂,术后常发生左心室衰竭。术中体外膜肺氧合(ECMO)支持而非体外循环下进行移植,甚至将 ECMO 延长至术后阶段,有助于克服这些问题。我们回顾了这一概念的应用经验。

方法

回顾性分析 2000 年 1 月至 2014 年 12 月期间,接受术中 ECMO 支持(伴或不伴预防性 ECMO 延长至术后)的特发性肺动脉高压双侧肺移植患者的临床资料。

结果

41 例患者入组研究。静脉-动脉 ECMO 支持延长至术后的中位时间为 2.5 天(1-40 天)。患者群体的 90 天、1 年、3 年和 5 年生存率分别为 92.7%、90.2%、87.4%和 87.4%。与同期未行 ECMO 延长至术后的 31 例特发性肺动脉高压患者相比,结果较为有利(83.9%、77.4%、77.4%和 77.4%;P=0.189)。此外,这些结果是该特定困难患者群体中报告的最佳结果之一。

结论

对于特发性肺动脉高压患者,术中静脉-动脉 ECMO 支持的双侧肺移植似乎提供了优于体外循环的结果。预防性将静脉-动脉 ECMO 延长至术后早期可提供稳定的术后条件,并进一步改善结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f948/5848802/1582d7dc808c/ezx212f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验